Tizzoni Alejandro Horacio purchased $98K of BLX

Tizzoni Alejandro Horacio (Chief Risk Officer) purchased 1,850 shares of BLADEX, INC. (BLX) at $53.00 on 2026-08-21.

Original reporting
SEC EDGAR · Tizzoni Alejandro Horacio
Published Aug 24, 2026, 3:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 3:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BLX
Neutral
medium confidence
Mentioned
$BLX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLXNeutralLow
01

Why it matters

The disclosed purchase adds marginal confidence in the company's risk outlook but is unlikely to move the stock materially.

02

Market read

Minor insider buy; limited trading relevance.

03

What to watch

Potential upcoming risk management initiatives not disclosed.

Relevance 4/10Novelty 5/10Timing: filing date 2026-08-24

Background

Form 4 filing discloses insider transactions; BLX is a publicly traded company.

Company-level read

Ticker impact

$BLXNeutralMedium confidence
Context

Chief Risk Officer purchased 1,850 shares for $98,050, increasing holdings to 79,901 shares.

Expected impact

Minimal short-term movement; potential slight upside if market perceives confidence.

Evidence & confidence

Purchase size is modest relative to market cap; insider role is senior but not executive.

Market effects

None significant; insider activity does not affect sector trends.

Limited to investors tracking BLX.

Low

Counterpoint

Insider purchase could be routine portfolio rebalancing, not a bullish signal.

Key entities

  • Tizzoni Alejandro Horacio

    Chief Risk Officer of Bladex, Inc.

  • Bladex, Inc.

    Issuer of ticker BLX.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BLXMed

Bladex Earnings Call Shows Record Growth Amid Margin Pressure

Banco Latinoamericano de Comercio (BLX) reported Q3 record portfolio growth of $15B, up 15% sequentially and 38% YoY. Net income rose 15% YoY to $63.2M but fell 5% sequentially due to higher costs and provisions. Management expects margin compression and lending spread pressure, citing intense competition for Latin American assets. The company maintained its dividend at $0.6875 per share.

$BLXHighAI 8/10

BLADEX, INC. (BLX): Financial results for Q3 2026

BLADEX, INC. (BLX) furnished an SEC Form 6-K — earnings release. o SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BLADEX, INC. (Registrant) Date: October 28, 2026 By: /s/ Annette van Hoorde de So

$BLXMedAI 8/10

Bladex Inc (BLX) Q3 2026 Earnings Call Highlights: Record Portfolio and Net Interest

Bladex Inc (BLX) reported Q3 2026 earnings with record commercial portfolio at $15B, up 15% QoQ, and net interest income at $79.8M, up 9% QoQ. Credit quality remained strong, but net interest margin faces pressure. Guidance includes full-year NIM compression to ~2.25%. Loan growth is concentrated in short-term exposures, potentially slowing 2027 growth. The Panama sovereign loan is dilutive to NIM but contributes to NII.

Med

Bladex Grants Panama a Record US$1 Billion Loan

Bladex, a Panama-based trade bank, has granted Panama's government a record US$1 billion loan. The senior loan, announced on 15 September 2026, is for general budgetary purposes. Panama has been diversifying its financing sources amid credit rating pressures.

$BLXHigh

BLADEX, INC. (BLX): Financial results for Q2 2026

BLADEX, INC. (BLX) furnished an SEC Form 6-K — earnings release. o SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BLADEX, INC. (Registrant) Date: July 28, 2026 By: /s/ Annette van Hoorde de Solís